Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2

Oncogene

Volumn 31, Issue 6, 2012, Pages 764-775

  Chao, A ^a   Lin, C Y ^a   Lee, Y S ^b,c   Tsai, C L ^a   Wei, P C ^a,d   Hsueh, S ^a   Wu, T I ^a   Tsai, C N ^d   Wang, C J ^a   Chao, A S ^a   Wang, T H ^a,b,d   Lai, C H ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c MING CHUAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Dab2; epithelial mesenchymal transition (EMT); microRNA; miR 187

Indexed keywords

DISABLED HOMOLOG 2; FOCAL ADHESION KINASE; LUCIFERASE; MICRORNA; MICRORNA 187; MICRORNA 200A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; TUMOR SUPPRESSOR GENE; UPREGULATION;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84856960678     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.269     Document Type: Article

References (40)

1. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Bast Jr RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. (1981). Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331-1337. (Pubitemid 12235035)
3. Berek JS, Friedlander M, Hacker NF. (2010). Epithelial ovarian, fallopian tube, and peritoneal cancer. In: Berek JS, Hacker NF (eds). Berek & Hacker's Gynecologic Oncology. Lippincott Williams & Wilkins, pp 444-508.
4. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S. (2010). Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29: 4237-4244.
5. Chao A, Wang TH, Lee YS, Hsueh S, Chao AS, Chang TC et al. (2006). Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 119: 91-98.
6. Chao A, Tsai CL, Wei PC, Hsueh S, Chao AS, Wang CJ et al. (2010). Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett 291: 99-107.
7. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. (2010). TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12: 286-293.
8. Choi JH, Choi KC, Auersperg N, Leung PC. (2006). Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells. Endocr Relat Cancer 13: 641-651. (Pubitemid 43886683)
9. Chung CM, Man C, Jin Y, Jin C, Guan XY, Wang Q et al. (2005). Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog 43: 165-174. (Pubitemid 40944241)
10. Eitan R, Kushnir M, Lithwick-Yanai G, David MB, Hoshen M, Glezerman M et al. (2009). Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol 114: 253-259.
11. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. (1999). Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 18: 3104-3113. (Pubitemid 29261231)
12. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
13. Griffiths-Jones S. (2004). The microRNA registry. Nucleic Acids Res 32: D109-D111. (Pubitemid 38081615)
14. Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O'Brien DI et al. (2010). Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J Clin Invest 120: 2842-2857.
15. Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK et al. (2009). A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 114: 457-464.
16. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P et al. (2007). MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707. (Pubitemid 47437445)
17. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43-66. (Pubitemid 46148091)
18. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, RingM et al. (2008). Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7: 35.
19. Lee YS, Chen CH, Tsai CN, Tsai CL, Chao A, Wang TH. (2009). Microarray labeling extension values: laboratory signatures for Affymetrix GeneChips. Nucleic Acids Res 37: e61.
20. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM et al. (2011). Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol Oncol 120: 135-144.
21. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. (2007). Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67: 10117-10122. (Pubitemid 350070782)
22. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. (2004). High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39: 167-169. (Pubitemid 38056091)
23. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC et al. (1994). Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol 52: 247-252. (Pubitemid 24064379)
24. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW et al. (1998). DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 16: 2381-2387. (Pubitemid 28226885)
25. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH et al. (2008). MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
26. Peter ME. (2009). Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8: 843-852.
27. Prunier C, Howe PH. (2005). Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem 280: 17540-17548. (Pubitemid 41389228)
28. Singh A, Settleman J. (2010). EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
29. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756. (Pubitemid 38697282)
30. Targetscan4.0 (2007). Prediction of microRNA targets. http://wwwtargetscanorg/cgi-bin/targetscan/vert-40/view-genecgi?taxid1/4 9606&gs1/4DAB2&showcnc1/40&shownc1/4 0.
31. Thiery JP. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
32. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, Chang YJ. et al. (2007). Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25: 2511-2523.
33. Tusher VG, Tibshirani R, Chu G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121. (Pubitemid 32397092)
34. Vetter G, Saumet A, Moes M, Vallar L, Le Bechec A, Laurini C et al. (2010). miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene 29: 4436-4448.
35. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
36. Wang TH,Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T et al. (1998). Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem 273: 4928-4936. (Pubitemid 28108645)
37. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. (Pubitemid 43357945)
38. Yang DH, Fazili Z, Smith ER, Cai KQ, Klein-Szanto A, Cohen C et al. (2006). Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background. Am J Pathol 169: 258-267.
39. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J et al. (2008). MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433. (Pubitemid 351380068)
40. Yang WL, Godwin AK, Xu XX. (2004). Tumor necrosis factor-alphainduced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk. Cancer Res 64: 1534-1540. (Pubitemid 38235627)